{
    "nctId": "NCT00356148",
    "officialTitle": "Phase IV Study of Determining the Efficacy of Ampicillin/Sulbactam Combination as Antibiotic Prophylaxis During Breast Cancer Surgery in Patients With a Body Mass Index (BMI) Over 25.",
    "inclusionCriteria": "* Women at any age with early stage breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) score of I-II.\n* Must be FEMALE\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Ductal carcinoma in situ (DCIS; stage 0 cancer),\n* Advanced or distant metastatic stage,\n* Receiving any neoadjuvant therapy,\n* History of receiving any antibiotics within prior 3 months,\n* History of immunodeficiency,\n* Having a remote infection,\n* History of reaction to study antibiotics,\n* Denial of signing the consent form."
}